Gene expression profiling of human gliomas reveals differences between GBM and LGA related to energy metabolism and notch signaling pathways
Margareto J, Leis O, Larrarte E, Idoate MA, Carrasco A, Lafuente JV.
LEIA Foundation, Pharmaceutical Development Unit, Leonardo de Vinci, 11; Alava Technologic Park, 01510 Miñano, Alava, Spain
Human malignant astrocytic tumors are the most common primary brain malignancies. Human gliomas are classified according to the extent of anaplasia or 'de-differentiation' appearance. Although this type of histological classification is widely accepted, the extensive heterogeneity of astrocytic tumors has made their pathological classification rather difficult.
New genome-scale high throughput technologies for gene expression profiling, such as DNA microarrays, are emerging as new tools to allow a more accurate identification and characterization of different tumor degrees by discovering new specific markers and pathways of each stage. Present work reports interesting results that might be useful to differentiate between tumor grades. Data presented here provides new evidences about the molecular basis underlying different tumor stages. In this sense, we identified key metabolic pathways, crucial for tumor progression, as being differentially regulated in different tumor stages. On the other hand, remarkable findings regarding Notch pathway are reported, as some members of this receptor family were found to be differentially expressed depending on the malignancy degree.
Our results clearly point out important molecular differences between different tumor stages and suggest that more studies are needed to understand specific molecular events characteristic of each stage. These types of studies represent a first step to deepen into the tumor physiology, which may potentially help for better and a more precise diagnosis of gliomas.
CITA DEL ARTÍCULO J Mol Neurosci. 2007;32(1):53-63